卫光生物2025年度向特定对象发行A股股票申请获得深圳证券交易所受理

Core Viewpoint - Shenzhen Wego Biological Products Co., Ltd. has received notification from the Shenzhen Stock Exchange regarding the acceptance of its application for a specific object issuance of A-shares, indicating a step forward in its capital raising efforts [1] Group 1: Company Announcement - The company announced that it received a notice from the Shenzhen Stock Exchange on October 10, 2025, regarding the acceptance of its application for issuing shares to specific investors [1] - The application documents submitted by the company were deemed complete by the Shenzhen Stock Exchange, leading to the decision to accept the application [1] - The issuance of A-shares is subject to approval from the Shenzhen Stock Exchange and registration consent from the China Securities Regulatory Commission, indicating that the process is not yet finalized [1] Group 2: Regulatory Process - The final approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission remains uncertain, highlighting the regulatory hurdles that the company must navigate [1] - The company commits to timely information disclosure based on the progress of this matter, emphasizing transparency in its operations [1]